Weiwei Hu

725 total citations
32 papers, 500 citations indexed

About

Weiwei Hu is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Weiwei Hu has authored 32 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Organic Chemistry. Recurrent topics in Weiwei Hu's work include Metal complexes synthesis and properties (7 papers), Microbial Metabolites in Food Biotechnology (3 papers) and Food composition and properties (3 papers). Weiwei Hu is often cited by papers focused on Metal complexes synthesis and properties (7 papers), Microbial Metabolites in Food Biotechnology (3 papers) and Food composition and properties (3 papers). Weiwei Hu collaborates with scholars based in China, Taiwan and Japan. Weiwei Hu's co-authors include Shaohua Gou, Shaohua Gou, Feihong Chen, Lei Fang, Xiaochao Huang, Chih‐Hsin Tang, Mian Wu, Hong Chen, Zhimei Wang and Heng‐Shan Wang and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Weiwei Hu

30 papers receiving 499 citations

Peers

Weiwei Hu
Carla Vetrugno Italy
Shuai Zhao China
Xing Lü China
Jelena Milovanović Serbia
Mohamed A. Abu el Maaty Germany
Bojana Stojanović Serbia
Xuejun Xu China
Jing Xia China
Carla Vetrugno Italy
Weiwei Hu
Citations per year, relative to Weiwei Hu Weiwei Hu (= 1×) peers Carla Vetrugno

Countries citing papers authored by Weiwei Hu

Since Specialization
Citations

This map shows the geographic impact of Weiwei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Hu more than expected).

Fields of papers citing papers by Weiwei Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Hu. The network helps show where Weiwei Hu may publish in the future.

Co-authorship network of co-authors of Weiwei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Hu. A scholar is included among the top collaborators of Weiwei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Hu. Weiwei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Wei, et al.. (2025). Different Efficacy of Five Soluble Dietary Fibers on Alleviating Loperamide-Induced Constipation in Mice: Influences of Different Structural Features. International Journal of Molecular Sciences. 26(3). 1236–1236. 3 indexed citations
3.
Shen, Yumeng, Weijun Zhao, Yuyuan Chen, et al.. (2025). PLAGL2 promotes HCC progression by recruiting tumour‐associated macrophages via CCL2/CCR2 signalling. British Journal of Pharmacology.
4.
5.
Liu, Zhikun, Lumei Dai, Ri-Zhen Huang, et al.. (2024). Discovery of dual-targeted molecules based on Olaparib and Rigosertib for triple-negative breast cancer with wild-type BRCA. Bioorganic & Medicinal Chemistry. 113. 117936–117936. 1 indexed citations
6.
Wang, Chen, Yanchao Xu, Yuyuan Chen, et al.. (2024). Stress-induced epinephrine promotes hepatocellular carcinoma progression via the USP10-PLAGL2 signaling loop. Experimental & Molecular Medicine. 56(5). 1150–1163. 9 indexed citations
7.
Wu, Yong, Yanghui Zhang, Weiwei Hu, et al.. (2023). Early Addition of Evolocumab to Statin Treatment in Patients with Acute Coronary Syndrome and Multivessel Disease Undergoing Percutaneous Coronary Intervention. Reviews in Cardiovascular Medicine. 24(9). 270–270. 3 indexed citations
8.
Zhang, Hao, et al.. (2023). The Association Between Erector Spinae Muscle Content and Chronic Heart Failure and Its Severity. ESC Heart Failure. 10(5). 2982–2989. 2 indexed citations
9.
Liu, Xingquan, et al.. (2023). Gastrointestinal Fermentable Polysaccharide Is Beneficial in Alleviating Loperamide-Induced Constipation in Mice. Nutrients. 15(20). 4364–4364. 9 indexed citations
10.
Li, Jin, Weiwei Hu, Xiaorong Li, et al.. (2022). Characterization of a Type VI Secretion System vgrG2 Gene in the Pathogenicity of Burkholderia thailandensis BPM. Frontiers in Microbiology. 12. 811343–811343. 3 indexed citations
11.
Yao, Ting, Weiwei Hu, Zhenghao Tang, et al.. (2022). Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis. Journal of Gastrointestinal Oncology. 13(5). 2472–2484. 15 indexed citations
12.
Zheng, Shufang, Ying Li, Yuchen Yao, et al.. (2021). 2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop. Pharmacological Research. 169. 105685–105685. 12 indexed citations
13.
Hu, Weiwei, et al.. (2017). Neuroprotective strategies for patients with acute myocardial infarction combined with hypoxic ischemic encephalopathy in the ICU. Hellenic Journal of Cardiology. 58(6). 427–431. 2 indexed citations
14.
Hu, Weiwei, et al.. (2017). Biotin-Pt (IV)-indomethacin hybrid: A targeting anticancer prodrug providing enhanced cancer cellular uptake and reversing cisplatin resistance. Journal of Inorganic Biochemistry. 175. 47–57. 64 indexed citations
15.
Chen, Hong, Feihong Chen, Weiwei Hu, & Shaohua Gou. (2017). Effective platinum(IV) prodrugs conjugated with lonidamine as a functional group working on the mitochondria. Journal of Inorganic Biochemistry. 180. 119–128. 33 indexed citations
16.
Chen, Feihong, Xiaochao Huang, Mian Wu, Shaohua Gou, & Weiwei Hu. (2016). A CK2-targeted Pt(IV) prodrug to disrupt DNA damage response. Cancer Letters. 385. 168–178. 42 indexed citations
17.
Xiao, Wenjin, Yingying Ke, Jian He, et al.. (2011). Polymorphisms in the human ALOX12 and ALOX15 genes are associated with peak bone mineral density in Chinese nuclear families. Osteoporosis International. 23(7). 1889–1897. 12 indexed citations
18.
Wang, Chun, Yiming Hu, Jin‐Wei He, et al.. (2011). Association between Low Density Lipoprotein Receptor-Related Protein 2 Gene Polymorphisms and Bone Mineral Density Variation in Chinese Population. PLoS ONE. 6(12). e28874–e28874. 7 indexed citations
19.
Hu, Cheng, Weiwei Hu, Congrong Wang, et al.. (2010). A common variant of NOS1AP is associated with QT interval duration in a Chinese population with Type 2 diabetes. Diabetic Medicine. 27(9). 1074–1079. 17 indexed citations
20.
Onuma, Takeshi A., Masatoshi Ban, Hiroshi Katsumata, et al.. (2010). Changes in gene expression for GH/PRL/SL family hormones in the pituitaries of homing chum salmon during ocean migration through upstream migration. General and Comparative Endocrinology. 166(3). 537–548. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Vetrugno Breakdown of academic impact, for papers by Shuai Zhao Breakdown of academic impact, for papers by Xing Lü Breakdown of academic impact, for papers by Jelena Milovanović Breakdown of academic impact, for papers by Mohamed A. Abu el Maaty Breakdown of academic impact, for papers by Bojana Stojanović Breakdown of academic impact, for papers by Xuejun Xu Breakdown of academic impact, for papers by Jing Xia
Rankless by CCL
2026